共有 29 笔近期内部人交易记录记录，涉及 Alto Neuroscience, Inc. (ANRO), 包括 22 笔买入 和 6 笔卖出. 内部人买入总额为 $15.96M 内部人卖出总额为 $3.27M.
近期活跃的重要内部人包括 Etkin Amit, Smith Nicholas Conrad, Hanley Jr. Michael Conick. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — ANRO
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-01 |
Etkin Amit |
President and CEO |
RSU 预扣税 |
6,227 |
$19.69 |
$122.61K |
1,233,949 |
| 2026-03-01 |
Smith Nicholas Conrad |
Chief Financial Officer & Cbo |
RSU 预扣税 |
2,806 |
$19.69 |
$55.25K |
24,060 |
| 2026-02-11 |
Hanley Jr. Michael Conick |
Chief Operating Officer |
限制性股票授予 (RSU) |
131,000 |
$16.71 |
$2.19M |
131,000 |
| 2026-02-11 |
Etkin Amit |
President and CEO |
限制性股票授予 (RSU) |
306,000 |
$16.71 |
$5.11M |
306,000 |
| 2026-02-11 |
Savitz Adam |
Chief Medical Officer |
限制性股票授予 (RSU) |
124,000 |
$16.71 |
$2.07M |
124,000 |
| 2026-02-11 |
Smith Nicholas Conrad |
Chief Financial Officer & Cbo |
限制性股票授予 (RSU) |
200,000 |
$16.71 |
$3.34M |
200,000 |
| 2026-01-02 |
Sanchez Ramiro |
Director |
限制性股票授予 (RSU) |
3,806 |
$16.59 |
$63.14K |
3,806 |
| 2026-01-02 |
Cox Christopher Nixon |
Director |
限制性股票授予 (RSU) |
7,189 |
$16.59 |
$119.27K |
7,189 |
| 2026-01-02 |
York Gwill |
Director |
限制性股票授予 (RSU) |
5,243 |
$16.59 |
$86.98K |
5,243 |
| 2026-01-02 |
Manji Husseini |
Director |
限制性股票授予 (RSU) |
4,228 |
$16.59 |
$70.14K |
4,228 |
| 2025-08-12 |
Sanchez Ramiro |
Director |
未知 |
- |
- |
- |
- |
| 2025-08-12 |
Sanchez Ramiro |
Director |
限制性股票授予 (RSU) |
3,928 |
$3.18 |
$12.49K |
3,928 |
| 2025-07-03 |
Hanley Jr. Michael Conick |
Chief Operating Officer |
股份退回 |
8,000 |
$14.88 |
$119.04K |
- |
| 2025-07-03 |
Etkin Amit |
President and CEO |
股份退回 |
247,290 |
$5.30 |
$1.31M |
- |
| 2025-07-03 |
Savitz Adam |
Chief Medical Officer |
股份退回 |
76,000 |
$4.20 |
$319.2K |
- |
| 2025-07-03 |
Smith Nicholas Conrad |
Chief Financial Officer & Cbo |
股份退回 |
90,000 |
$14.88 |
$1.34M |
- |
| 2025-05-13 |
Dreyfus Andrew |
Director |
限制性股票授予 (RSU) |
15,287 |
$2.37 |
$36.23K |
15,287 |
| 2025-05-13 |
Cox Christopher Nixon |
Director |
限制性股票授予 (RSU) |
15,287 |
$2.37 |
$36.23K |
15,287 |
| 2025-05-13 |
York Gwill |
Director |
限制性股票授予 (RSU) |
15,287 |
$2.37 |
$36.23K |
15,287 |
| 2025-05-13 |
Manji Husseini |
Director |
限制性股票授予 (RSU) |
15,287 |
$2.37 |
$36.23K |
15,287 |
| 2025-02-05 |
Hanley Jr. Michael Conick |
Chief Operating Officer |
限制性股票授予 (RSU) |
125,000 |
$4.20 |
$525K |
125,000 |
| 2025-02-05 |
Etkin Amit |
President and CEO |
限制性股票授予 (RSU) |
215,000 |
$4.20 |
$903K |
215,000 |
| 2025-02-05 |
Savitz Adam |
Chief Medical Officer |
限制性股票授予 (RSU) |
76,000 |
$4.20 |
$319.2K |
76,000 |
| 2025-02-05 |
Smith Nicholas Conrad |
Chief Financial Officer & Cbo |
限制性股票授予 (RSU) |
135,000 |
$4.20 |
$567K |
135,000 |
| 2025-01-02 |
Cox Christopher Nixon |
Director |
限制性股票授予 (RSU) |
25,236 |
$4.38 |
$110.53K |
25,236 |
| 2025-01-02 |
York Gwill |
Director |
限制性股票授予 (RSU) |
19,558 |
$4.38 |
$85.66K |
19,558 |
| 2025-01-02 |
Manji Husseini |
Director |
限制性股票授予 (RSU) |
14,195 |
$4.38 |
$62.17K |
14,195 |
| 2024-07-10 |
Savitz Adam |
Chief Medical Officer |
知情买入 |
2,931 |
$13.22 |
$38.75K |
39,851 |
| 2024-07-09 |
Savitz Adam |
Chief Medical Officer |
知情买入 |
10,681 |
$12.53 |
$133.83K |
35,532 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
